1 FEMALE ROMK NULL MICE MANIFEST MORE SEVERE BARTTER II PHENOTYPE ON RENAL FUNCTION AND HIGHER PGE 2 PRODUCTION

[1]  G. Burckhardt,et al.  Gender differences in kidney function , 2007, Pflügers Archiv - European Journal of Physiology.

[2]  D. Pearse,et al.  Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. , 2005, Kidney international.

[3]  S. Waldegger,et al.  Salt handling in the distal nephron: lessons learned from inherited human disorders. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  J. Pollock,et al.  Downloaded from http://hyper.ahajournals.org / by guest on February 21, 2013Sexual Dimorphism in Renal Production of Prostanoids in Spontaneously Hypertensive Rats , 2022 .

[5]  I. Armando,et al.  Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat , 2005, Regulatory Peptides.

[6]  H. Seyberth,et al.  The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome. , 2004, Acta physiologica Scandinavica.

[7]  V. Koch,et al.  Bartter syndrome: benefits and side effects of long-term treatment , 2004, Pediatric Nephrology.

[8]  G. Giebisch,et al.  ROMK is required for expression of the 70-pS K channel in the thick ascending limb. , 2004, American journal of physiology. Renal physiology.

[9]  W. Proesmans,et al.  Growth from birth to adulthood in a patient with the neonatal form of bartter syndrome , 1988, Pediatric Nephrology.

[10]  M. Imai,et al.  Effects of prostaglandins on Na transport in isolated collecting tubules , 1978, Pflügers Archiv.

[11]  J. Neugarten.  Gender and the progression of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[12]  T. Doetschman,et al.  Impaired Renal NaCl Absorption in Mice Lacking the ROMK Potassium Channel, a Model for Type II Bartter's Syndrome* , 2002, The Journal of Biological Chemistry.

[13]  G. Giebisch,et al.  Absence of Small Conductance K+ Channel (SK) Activity in Apical Membranes of Thick Ascending Limb and Cortical Collecting Duct in ROMK (Bartter's) Knockout Mice* , 2002, The Journal of Biological Chemistry.

[14]  H. Seyberth,et al.  Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. , 2002, Kidney international.

[15]  M. Breyer,et al.  Physiological regulation of cyclooxygenase-2 in the kidney. , 2001, American journal of physiology. Renal physiology.

[16]  M. Breyer,et al.  Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. , 2000, Kidney international.

[17]  R. Kalb,et al.  Defective fluid and HCO(3)(-) absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice. , 2000, American journal of physiology. Renal physiology.

[18]  P. Igarashi,et al.  Uncompensated polyuria in a mouse model of Bartter's syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. E. Faunce,et al.  Estrogen mediates the sex difference in post-burn immunosuppression. , 2000, The Journal of endocrinology.

[20]  G. Giebisch,et al.  Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice. , 1999, The American journal of physiology.

[21]  G. FitzGerald,et al.  Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. , 1999, The Journal of pharmacology and experimental therapeutics.

[22]  I. Ichikawa,et al.  Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. , 1999, The Journal of clinical investigation.

[23]  G. Giebisch,et al.  A tyrosine-based signal regulates H-K-ATPase-mediated potassium reabsorption in the kidney. , 1998, The American journal of physiology.

[24]  M. Konrad,et al.  A Hyperprostaglandin E Syndrome Mutation in Kir1.1 (Renal Outer Medullary Potassium) Channels Reveals a Crucial Residue for Channel Function in Kir1.3 Channels* , 1998, The Journal of Biological Chemistry.

[25]  L. Bianchi,et al.  Functional consequences of ROMK mutants linked to antenatal Bartter's syndrome and implications for treatment. , 1998, Human molecular genetics.

[26]  H. Omran,et al.  Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome , 1998, Pediatric Nephrology.

[27]  G. Giebisch,et al.  Renal K+ channels: structure and function. , 1997, Annual review of physiology.

[28]  R. Carey,et al.  The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. , 1997, The Journal of clinical investigation.

[29]  D. Kaji,et al.  Prostaglandin E2 inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells. , 1996, The American journal of physiology.

[30]  J. Craig,et al.  Indomethacin for renal impairment in neonatal Bartter's syndrome , 1996, The Lancet.

[31]  T. Ogihara,et al.  [Bartter syndrome]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.

[32]  S. Silbiger,et al.  The impact of gender on the progression of chronic renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  L. Peterson,et al.  Endogenous prostaglandin E2 mediates inhibition of rat thick ascending limb Cl reabsorption in chronic hypercalcemia. , 1993, The Journal of clinical investigation.

[34]  K. Kokko,et al.  Inhibition of apical Na+ channels in rabbit cortical collecting tubules by basolateral prostaglandin E2 is modulated by protein kinase C. , 1992, The Journal of clinical investigation.

[35]  H. Seyberth,et al.  Increased Renal Biosynthesis of Prostaglandin E2 and Thromboxane B2 in Human Congenital Obstructive Uropathy , 1990, Pediatric Research.

[36]  M. Zeidel,et al.  Prostaglandin E2 inhibits Na+-K+-ATPase activity in the inner medullary collecting duct. , 1989, The American journal of physiology.

[37]  R. Kunau,et al.  Angiotensin II-stimulated prostaglandin production by canine renal afferent arterioles. , 1988, The American journal of physiology.

[38]  A. Fujimura,et al.  Role of angiotensin II in renal prostaglandin E2 production after furosemide administration. , 1988, Hypertension.

[39]  N. Farman,et al.  Segmental synthesis and actions of prostaglandins along the nephron. , 1987, The American journal of physiology.

[40]  P. Klotman,et al.  Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. , 1986, The American journal of physiology.

[41]  P. Needleman,et al.  Renal arachidonic acid metabolism and cellular changes in the rabbit renal vein constricted kidney: inflammation as a common process in renal injury models. , 1984, Prostaglandins.

[42]  C. Cerletti,et al.  Correction of increased prostacyclin synthesis in Bartter's syndrome by indomethacin treatment. , 1980, Prostaglandins and medicine.

[43]  J. Gill.  Bartter's syndrome. , 1980, Annual review of medicine.

[44]  A. Simopoulos.  Growth characteristics in patients with Bartter's syndrome. , 1979, Nephron.

[45]  J. Gill,et al.  Hyperplasia of the Juxtaglomerular Complex with Hyperaldosteronism and Hypokalemic Alkalosis. , 1963 .